Ovarian cancer may be detected with a pelvic exam, but it might be too small to identify with this method. Imaging, including transvaginal ultrasound or non-invasive abdominal imaging may reveal the ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...

"Symptoms of ovarian cancer are vague, non-specific, and occur with a variety of conditions," Dr. Priyal Dholakiya, MD, a ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...

First, the guidelines recommend that patients with suspected stage III-IV epithelial ovarian cancer be evaluated by a gynecologic oncologist before starting therapy to determine if they are ...

At just 31 years old, Cameron Gourley had just gotten married when she noticed a lump during her typical self-exam.

Previously, Anixa and Moffitt had secured a single patient IND approval for an additional dose for a patient whose biopsy showed ... advance the treatment of ovarian cancer with CAR-T therapy.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...

A Pap smear or Pap test is a screening test for cervical cancer. There’s currently no easy and reliable early screening test for ovarian cancer. A Pap smear or Pap test doesn’t help doctors ...